ArticleThe journal of pediatrics: X2020

A Randomized Study of Safety and Efficacy of Two Doses of Ambrisentan to Treat Pulmonary Arterial Hypertension in Pediatric Patients Aged 8 Years up to 18 Years.

Dunbar Ivy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.